Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
🧲 New MRI Technique to Speed Up Multi-Contrast MRI Scans and Advance Early Alzheimer’s Biomarker Discovery
A new publication from PREDICTOM introduces a promising method to dramatically accelerate multi-contrast brain MRI scans, without sacrificing image quality. The technique could pave the way for earlier and more accessible diagnosis of neurodegenerative diseases like Alzheimer’s disease.
News
🧠 New Blood Test Clue in Alzheimer’s: Syndecan-3 Emerges as a Promising Biomarker
In a breakthrough that could reshape early detection of Alzheimer’s disease, researchers have identified a novel blood-based biomarker that may help distinguish Alzheimer’s patients from healthy individuals—potentially paving the way for simpler, less invasive diagnostics.
News
Over 50? Join the PREDICTOM Study and Help Advance Brain Health!
Would you like to help us understand how to reduce the risk of developing Alzheimer’s Disease?
Did you know that you can reduce your risk of developing dementia?
The risk of developing dementia is influenced by various factors, with several of them being modifiable by the actions we take on a daily basis. On this page you can learn more about what actions you can take to reduce your risk.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.